ExoVectory acquires pre-seed funding ErasSupport

ExoVectory has obtained an ErasSupport grant consisting of growth capital and know-how to strengthen its developments on exosome therapies. The grant will be used to perform further studies on the use of exosomes to treat devastating types of cancer.

Explore our exosome delivery technology or contact ExoVectory about partnerships and investment.